Spending the cost of Bortezomib ACTe launch for the first injection of patients in need.

October 20, 2020

Author: Acteropharma

Considering the current situation in the country and taking into account the needs of patients, Actero Company decided to spend all the costs related to the unveiling of the drug Bortezomib ACTe on the first free injection of patients’ candidates receiving Bortezomib.

Therefore, by delivering the drug sample to physicians specializing in this field, treatment coverage began in a number of eligible patients.

Last News

رویداد آگاهی از سرطان پستان
November 3, 2026

Author:

Acteropharma
According to Actover Group’s Public Relations Department, the event brought together participants, physicians and pharmacists from across the Group to highlight the importance of early detection and timely treatment of breast cancer. Attendees also received information about breast cancer risk factors, warning signs, self-examination and diagnostic methods.
روز کارگر-EN-08
May 1, 2025

Author:

Acteropharma
International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity.
the 9th International Radio-Oncology Congress
March 11, 2025

Author:

Acteropharma
From January 30 to February 1, the 9th International Radio-Oncology Congress was held with the aim of advancing scientific programs in the community and supporting the expansion of cancer research.